Centaur Pharmaceuticals   Report issue

For profit Phase 2
Founded: Mumbai India (1978)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
1999
NCT00002414
First Marketed Drug
2016
lamivudine (epivir)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CENTAUR PHARMS PVT